Skip to main content

Investeringsforeningen Lån & Spar Invest – Indkaldelse til ekstraordinær generalforsamling

Investeringsforeningen Lån & Spar Invest indkalder til ekstraordinær generalforsamling, der afholdes tirsdag den 29. september 2026, kl. 9.00. Indkaldelsen med sted, dagsorden samt fuldstændige forslag er vedhæftet. Eventuelle henvendelser vedrørende denne meddelelse bedes rettet til undertegnede på tlf. 38 14 66 00. Med venlig hilsenInvest Administration A/S Niels Erik EberhardDirektørAttachmentsLSI Indkaldelse til ekstraordinær generalforsamling september 2026LSI_Vedtægter_EGF 2026_fusion mark-upLSI Fusionsplan og -redegørelse_juni 2026 Underskrevet

Continue reading

Investeringsforeningen Lån & Spar Invest – Prospekt

Opdateret prospekt for Investeringsforeningen Lån & Spar Invest offentliggøres dags dato. Prospektet er opdateret som følge af udvidelse af porteføljestørrelsen for afdeling Verden Selection. Prospektet er vedhæftet og kan også findes på foreningens hjemmeside www.lsinvest.dk. Henvendelser vedrørende denne meddelelse bedes rettet til undertegnede på telefon 38 14 66 00. Med venlig hilsen Niels Erik EberhardDirektørAttachmentLSI Prospekt september 2026 inkl. SFDR

Continue reading

KPN announces € 500m Hybrid Bond and Tender Offer

Today, Koninklijke KPN N.V. (“KPN”) announces its intention to issue a EUR 500m perpetual non-call 5.25 year subordinated bond (the “Hybrid Bond”). The proceeds from the new Hybrid Bond offering will be used for general corporate purposes and refinancing of existing indebtedness. The Hybrid Bond is expected to be treated for 50% as equity and 50% as debt by S&P and Fitch and will be accounted for as equity under IFRS. Simultaneously, KPN announces a debt tender offer to repurchase any and all of its EUR 500m perpetual hybrid capital securities with first reset date on 21 December 2027 (ISIN: XS2486270858) (the “Offer”). Terms of the Offer are set out in the Tender Offer Memorandum dated 1 September 2026, which can be obtained from the Tender Agent. The purpose of these transactions is to proactively manage KPN’s hybrid capital and...

Continue reading

GLOBAL POWER SOLUTIONS PROVIDES UPDATE ON POTENTIAL REACTIVATION OF PERU HOSPITAL PROJECT

Vancouver, British Columbia, Sept. 01, 2026 (GLOBE NEWSWIRE) — Global Power Solutions Corp. (TSXV: PWER) (FSE: NJA) (“Global Power” or the “Company”) is pleased to provide an update regarding the potential reactivation of a previously announced hospital development project in Peru involving EsSalud, Peru’s Social Health Insurance authority. The Company’s predecessor, Minaean SP Construction Corp., previously entered into a Memorandum of Understanding (“MOU”) with EsSalud in connection with the proposed development and construction of a 224-bed hospital in Chiclayo, Lambayeque Province, Peru. The project did not advance during the period of political and administrative change in Peru, and the previous MOU has since expired. Representatives of the current EsSalud administration have recently expressed interest in reopening discussions...

Continue reading

Cygnus Metals Limited: Conditional Approval of TSX Listing for CAML

TORONTO and PERTH, Western Australia, Sept. 01, 2026 (GLOBE NEWSWIRE) — Cygnus Metals Limited (ASX: CY5; TSXV: CYG; OTCQB: CYGGF) (“Cygnus” or the “Company”) notes the announcement by Central Asia Metals plc (“CAML”) on 1 September 2026 that that the Toronto Stock Exchange (“TSX”) has conditionally approved the listing on the TSX of the shares in CAML, including the new shares (“New CAML Shares”) that will be issued to the shareholders in Cygnus in exchange for their fully paid ordinary shares in Cygnus pursuant to the terms of the previously announced Scheme of Arrangement (“Scheme”) between Cygnus and CAML. The shares will trade on the TSX under the trading symbol ‘CAML’. Final approval of the listing is subject to certain customary conditions of the TSX including, naturally, successful completion of the Scheme. As noted in the...

Continue reading

Aedifica NV/SA: 2026 half year financial report

Please find below Aedifica’s 2026 half year financial report. Creating Europe’s leading healthcare REITOn 10 March 2026, Aedifica acquired control over Cofinimmo with 80% of the shares tendered during the exchange offer On 1 July 2026, Cofinimmo was delisted from Euronext following a legal merger by absorption with Aedifica A new Board of Directors and Executive Committee have been appointedRobust operational performance driving strong resultsEPRA Earnings per share increased to €2.71 (+5% compared to 30 June 2025), highlighting the accretiveness of the Cofinimmo transaction EPRA Earnings amounted to €189.9 million (+54% compared to 30 June 2025) Rental income increased to €292.3 million (+62% compared to 30 June 2025) 1.7% increase in rental income on a like-for-like basis in H1 Weighted average unexpired lease term of 15 years...

Continue reading

Bavarian Nordic Launches First Tranche of New Share Buy-Back Program

COPENHAGEN, Denmark, September 1, 2026 – Bavarian Nordic A/S (OMX: BAVA) today launches the first tranche of the new share buy-back program announced on August 21, under which the Company intends to repurchase own shares for up to DKK 750 million. The first tranche will comprise buy-back of shares for up to DKK 250 million. The purpose of the new share buy-back program is to adjust the capital structure, through subsequent cancellation of shares repurchased under this program, subject to any necessary additional corporate resolutions, as applicable. The share buy-back program is initiated pursuant to the authorization granted at the annual general meeting on April 21, 2026, and in accordance with Regulation (EU) No. 596/2014 (as amended) of the European Parliament and of the Council on market abuse and Commission Delegated Regulation (EU)...

Continue reading

Novartis remibrutinib, a high-efficacy oral BTK inhibitor, significantly reduces relapse rates and shows favorable safety profile in Phase III RMS trials

Ad hoc announcement pursuant to Art. 53 LR   REMODEL-1/-2 trials met their primary endpoint, significantly reducing annualized relapse rate (ARR) vs teriflunomide in people living with relapsing multiple sclerosis (RMS)1    Trials showed superiority of remibrutinib vs. teriflunomide on all key secondary endpoints within each trial, including reduction of MRI lesions1     A clinically meaningful delay in disability progression was achieved, including a positive trend in 3mCDP and nominally significant 6mCDP in preplanned combined analysis of REMODEL-1/-21    Remibrutinib demonstrated a favorable safety profile with no liver safety signal, consistent with remibrutinib in chronic spontaneous urticaria (CSU)1    Novartis to present late-breaking data at MSToronto2026 and plans to submit to health authorities globally   Basel, September...

Continue reading

Consolidated Unaudited Interim Report of AS PRFoods for the 4th quarter and 12 months of 2025/2026 financial year

MANAGEMENT COMMENTARYPRFoods’ fourth quarter of the financial year continued to be affected by a challenging economic environment, characterised by weak consumer demand, price pressure and uncertainty in the retail sector. Management remained focused on stabilising operations and implementing the restructuring plan. Fourth‑quarter revenue amounted to EUR 3.4 million, a decrease of 8% compared to the same period last year. Gross profit declined to EUR 0.4 million, mainly due to lower production volumes in the Estonian production unit and volatility in raw material prices. EBITDA improved year‑on‑year by EUR 0.1 million and totalled EUR ‑0.3 million. Operating loss amounted to EUR ‑0.6 million, which is EUR 0.2 million better than in the same period last year. Net profit for the quarter was EUR 0.1 million, but the result was significantly...

Continue reading

Cerebras and Compute Nordic Finland Announce New 165 MW AI Data Centre in Mikkeli, Finland

Facility backed by seven-year contracted capacity agreement and estimated €1.0–1.7 billion in regional investment for local development and employment MIKKELI, Finland, Sept. 01, 2026 (GLOBE NEWSWIRE) — Cerebras Systems (NASDAQ: CBRS) today announced a new AI data centre in Mikkeli, Finland, developed in partnership with Compute Nordic Finland. The facility will scale in phases to 165 MW of contracted IT capacity to deliver high-density AI compute with construction on the initial 50 MW phase already under way. The agreement, formalized through a series of service orders each with seven-year contract terms, gives Cerebras long-term, purpose-built infrastructure to support growing global demand for its AI compute platform, while providing the Mikkeli region a long-term industrial anchor with significant estimated revenue and sustained...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.